ArticleBlood advances2026

HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease.

Mattias Häger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.